| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 1999-2001, Copyright © 1996 by Endocrine Society
ARTICLES |
NW Cheung, C Liddle, S Coverdale, JC Lou and SC Boyages
Department of Diabetes and Endocrinology, University of Sydney at Westmead Hospital, NSW, Australia.
We used the antipyrine clearance test (APC) to examine the effect of growth hormone (GH) therapy on hepatic cytochrome P450 (CYP) enzyme activity. Eleven GH deficient adults were randomized to receive GH or placebo for 6 months, all subjects subsequently received GH. Before treatment, APC was below the normal range in six subjects. We found an increase in APC in the subjects randomized to receive GH compared to those on placebo (median change +0.14 ml/min/kg [range + 0.04 to + 0.20]vs -0.04 ml/min/kg [range -0.07 to + 0.04], p = 0.011). The stimulatory effect of GH on drug metabolism was confirmed by the data for 3 months GH treatment in all 11 subjects, with APC increasing from 0.33 ml/min/kg (range 0.22 to 0.69) to 0.50 ml/min/kg (range 0.27 to 0.83), p = 0.018). These data indicate that GH modulates hepatic CYP activity. This has important clinical implications, as the hepatic metabolism of drugs and hormones may be altered in patients undergoing GH therapy.
This article has been cited by other articles:
 |
|
 |
|
  R. N. Dhir, W. Dworakowski, C. Thangavel, and B. H. Shapiro Sexually Dimorphic Regulation of Hepatic Isoforms of Human Cytochrome P450 by Growth Hormone J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 87 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Hoffman, B. M. K. Biller, D. Cook, J. Baptista, B. L. Silverman, L. Dao, K. M. Attie, P. Fielder, T. Maneatis, B. Lippe, et al. Efficacy of a Long-Acting Growth Hormone (GH) Preparation in Patients with Adult GH Deficiency J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6431 - 6440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Dhir and B. H. Shapiro Interpulse growth hormone secretion in the episodic plasma profile causes the sex reversal of cytochrome P450s in senescent male rats PNAS, December 9, 2003; 100(25): 15224 - 15228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Stevens, R. N. Hines, C. Gu, S. B. Koukouritaki, J. R. Manro, P. J. Tandler, and M. J. Zaya Developmental Expression of the Major Human Hepatic CYP3A Enzymes J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 573 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Jaffe, D. K. Turgeon, K. Lown, R. Demott-Friberg, and P. B. Watkins Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1008 - E1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Allen, J. R. Julius, T. J. Breen, and K. M. Attie Treatment of Glucocorticoid-Induced Growth Suppression with Growth Hormone J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2824 - 2829. [Abstract] [Full Text]
|
|
|
|
|
|
C. Liddle, B. J. Goodwin, J. George, M. Tapner, and G. C. Farrell Separate and Interactive Regulation of Cytochrome P450 3A4 by Triiodothyronine, Dexamethasone, and Growth Hormone in Cultured Hepatocytes J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2411 - 2416. [Abstract] [Full Text]
|
|
|
|
|
|
R. C. Cuneo, S. Judd, J. D. Wallace, D. Perry-Keene, H. Burger, S. Lim-Tio, B. Strauss, J. Stockigt, D. Topliss, F. Alford, et al. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 107 - 116. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
